-
Je něco špatně v tomto záznamu ?
The environmental pollutant and carcinogen 3-nitrobenzanthrone and its human metabolite 3-aminobenzanthrone are potent inducers of rat hepatic cytochromes P450 1A1 and -1A2 and NAD(P)H:quinone oxidoreductase
Stiborová M, Dracínská H, Hájková J, Kaderábková P, Frei E, Schmeiser HH, Soucek P, Phillips DH, Arlt VM
Jazyk angličtina Země Spojené státy americké
NLK
Open Access Digital Library
od 1997-01-01
- MeSH
- adukty DNA MeSH
- benz(a)anthraceny farmakologie MeSH
- enzymová indukce MeSH
- financování organizované MeSH
- jaterní mikrozomy enzymologie účinky léků MeSH
- játra enzymologie účinky léků MeSH
- karcinogeny farmakologie MeSH
- králíci MeSH
- krysa rodu rattus MeSH
- látky znečišťující životní prostředí farmakologie MeSH
- lidé MeSH
- messenger RNA analýza MeSH
- NAD(P)H dehydrogenasa (chinon) biosyntéza MeSH
- potkani Wistar MeSH
- systém (enzymů) cytochromů P-450 biosyntéza genetika MeSH
- zvířata MeSH
- Check Tag
- králíci MeSH
- krysa rodu rattus MeSH
- lidé MeSH
- mužské pohlaví MeSH
- zvířata MeSH
3-Nitrobenzanthrone (3-NBA), a suspected human carcinogen occurring in diesel exhaust and air pollution, and its human metabolite 3-aminobenzanthrone (3-ABA) were investigated for their ability to induce biotransformation enzymes in rat liver and the influence of such induction on DNA adduct formation by the compounds. Rats were treated (i.p.) with 0.4, 4, or 40 mg/kg body weight 3-NBA or 3-ABA. When hepatic cytosolic fractions from rats treated with 40 mg/kg body weight 3-NBA or 3-ABA were incubated with 3-NBA, DNA adduct formation, measured by 32P-postlabeling analysis, was 10-fold higher in incubations with cytosols from pretreated rats than with controls. The increase in 3-NBA-derived DNA adduct formation corresponded to a dose-dependent increase in protein levels and enzymatic activity of NAD(P)H:quinone oxidoreductase (NQO1). NQO1 is the major enzyme reducing 3-NBA in human and rat livers. Incubations of 3-ABA with hepatic microsomes of rats treated with 3-NBA or 3-ABA (40 mg/kg body weight) led to as much as a 12-fold increase in 3-ABA-derived DNA adduct formation compared with controls. The observed stimulation of DNA adduct formation by both compounds was attributed to their potential to induce protein expression and enzymatic activity of cytochromes P450 1A1 and/or -1A2 (CYP1A1/2), the major enzymes responsible for 3-ABA activation in human and rat livers. Collectively, these results demonstrate for the first time, to our knowledge, that by inducing hepatic NQO1 and CYP1A1/2, both 3-NBA and 3-ABA increase the enzymatic activation of these two compounds to reactive DNA adduct-forming species, thereby enhancing their own genotoxic potential.
- 000
- 00000naa 2200000 a 4500
- 001
- bmc07527977
- 003
- CZ-PrNML
- 005
- 20111210144150.0
- 008
- 090831s2006 xxu e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Stiborová, Marie, $d 1950-2020 $7 jo2005259907
- 245 14
- $a The environmental pollutant and carcinogen 3-nitrobenzanthrone and its human metabolite 3-aminobenzanthrone are potent inducers of rat hepatic cytochromes P450 1A1 and -1A2 and NAD(P)H:quinone oxidoreductase / $c Stiborová M, Dracínská H, Hájková J, Kaderábková P, Frei E, Schmeiser HH, Soucek P, Phillips DH, Arlt VM
- 314 __
- $a Department of Biochemistry, Faculty of Science, Charles University, Albertov 2030, 128 40 Prague 2, Czech Republic. stiborov@natur.cuni.cz
- 520 9_
- $a 3-Nitrobenzanthrone (3-NBA), a suspected human carcinogen occurring in diesel exhaust and air pollution, and its human metabolite 3-aminobenzanthrone (3-ABA) were investigated for their ability to induce biotransformation enzymes in rat liver and the influence of such induction on DNA adduct formation by the compounds. Rats were treated (i.p.) with 0.4, 4, or 40 mg/kg body weight 3-NBA or 3-ABA. When hepatic cytosolic fractions from rats treated with 40 mg/kg body weight 3-NBA or 3-ABA were incubated with 3-NBA, DNA adduct formation, measured by 32P-postlabeling analysis, was 10-fold higher in incubations with cytosols from pretreated rats than with controls. The increase in 3-NBA-derived DNA adduct formation corresponded to a dose-dependent increase in protein levels and enzymatic activity of NAD(P)H:quinone oxidoreductase (NQO1). NQO1 is the major enzyme reducing 3-NBA in human and rat livers. Incubations of 3-ABA with hepatic microsomes of rats treated with 3-NBA or 3-ABA (40 mg/kg body weight) led to as much as a 12-fold increase in 3-ABA-derived DNA adduct formation compared with controls. The observed stimulation of DNA adduct formation by both compounds was attributed to their potential to induce protein expression and enzymatic activity of cytochromes P450 1A1 and/or -1A2 (CYP1A1/2), the major enzymes responsible for 3-ABA activation in human and rat livers. Collectively, these results demonstrate for the first time, to our knowledge, that by inducing hepatic NQO1 and CYP1A1/2, both 3-NBA and 3-ABA increase the enzymatic activation of these two compounds to reactive DNA adduct-forming species, thereby enhancing their own genotoxic potential.
- 650 _2
- $a financování organizované $7 D005381
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a benz(a)anthraceny $x farmakologie $7 D001551
- 650 _2
- $a karcinogeny $x farmakologie $7 D002273
- 650 _2
- $a systém (enzymů) cytochromů P-450 $x biosyntéza $x genetika $7 D003577
- 650 _2
- $a adukty DNA $7 D018736
- 650 _2
- $a látky znečišťující životní prostředí $x farmakologie $7 D004785
- 650 _2
- $a enzymová indukce $7 D004790
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a játra $x enzymologie $x účinky léků $7 D008099
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a jaterní mikrozomy $x enzymologie $x účinky léků $7 D008862
- 650 _2
- $a NAD(P)H dehydrogenasa (chinon) $x biosyntéza $7 D016660
- 650 _2
- $a messenger RNA $x analýza $7 D012333
- 650 _2
- $a králíci $7 D011817
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 700 1_
- $a Dračínská, Helena $7 xx0077061
- 700 1_
- $a Hájková, Jana, $d 1981- $7 xx0121178
- 700 1_
- $a Kadeřábková, Pavla. $7 _AN036391
- 700 1_
- $a Frei, Eva. $7 _AN036392
- 700 1_
- $a Schmeiser, Heinz H.
- 700 1_
- $a Souček, Pavel $7 xx0060511
- 700 1_
- $a Phillips, David H.
- 700 1_
- $a Arlt, Volker M. $7 xx0074763
- 773 0_
- $w MED00001446 $t Drug metabolism and disposition $g Roč. 34, č. 8 (2006), s. 1398-1405 $x 0090-9556
- 910 __
- $a ABA008 $b x $y 8
- 990 __
- $a 20090310084605 $b ABA008
- 991 __
- $a 20111128100831 $b ABA008
- 999 __
- $a ok $b bmc $g 673517 $s 532782
- BAS __
- $a 3
- BMC __
- $a 2006 $b 34 $c 8 $d 1398-1405 $i 0090-9556 $m Drug metabolism and disposition $x MED00001446
- LZP __
- $a 2009-B4/ipme